Haplotypes of four novel single nucleotide polymorphisms in the nicotinic acetylcholine receptor beta2-subunit (CHRNB2) gene show no association with smoking initiation or nicotine dependence

Am J Med Genet. 2000 Oct 9;96(5):646-53.

Abstract

Several types of evidence, including experiments with mice that lack the nicotinic acetylcholine receptor beta2-subunit gene (CHRNB2), have suggested that a beta2-containing nicotinic receptor is necessary for at least some of the reinforcing properties of nicotine. However, sequence variations in CHRNB2 have not been reported, and its role in influencing human smoking behavior and nicotine dependence is not known. We screened most of the introns and exons and found five novel single nucleotide polymorphisms (SNPs). We tested four of these SNPs in three large, carefully selected samples: nonsmokers (n = 317) and regular smokers low levels of nicotine dependence (ND, n = 238), or smokers with high-ND (n = 317). None of the four polymorphisms we tested, nor their estimated haplotypes, were associated with smoking initiation or progression to nicotine dependence.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • DNA / genetics
  • Female
  • Gene Frequency
  • Genotype
  • Haplotypes / genetics*
  • Humans
  • Linkage Disequilibrium
  • Male
  • Polymorphism, Single Nucleotide*
  • Receptors, Nicotinic / genetics*
  • Smoking / genetics*
  • Tobacco Use Disorder / genetics*

Substances

  • Receptors, Nicotinic
  • nicotinic receptor beta2
  • DNA